Food and supplement products containing cannabidiol (CBD) have risen in popularity over the past few years and have been misleadingly marketed as a cure-all for many medical conditions, including cancer, epilepsy, anxiety, depression, insomnia, pain, and diabetes. At the same time, there is mounting pressure to legalize non-prescription CBD products, which may pose significant safety risks to consumers. For example, consumers cannot be certain of the potency, purity, or appropriate dosing of CBD products, which can lead to harm. Additionally, some companies have made misleading claims about the therapeutic purpose of their products, and others have sold adulterated products containing harsh chemicals or undisclosed quantities of THC.
States have begun introducing legislation to provide greater oversight and regulation of the marketing and sale of products containing CBD. Use the map below to explore legislation related to this issue.